Embody vs NuuVim
Embody and NuuVim both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Embody
Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy
Visit Embody →If you are choosing between Embody and NuuVim, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Embody leads our six-part score, 9.3 to 7.7.
Embody vs NuuVim price
Embody and NuuVim start at the same figure, $79 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $79 a month; tirzepatide is cheaper at Embody ($129 a month vs $133 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Embody prices compounded injections and an oral option, while NuuVim prices compounded injections, an oral option and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, NuuVim is the only one of the two with a brand-name price.
Where each one treats patients
Embody lists 50 states, and NuuVim does not publish where it ships.
Pricing
Embody
'$79/mo flat forever' (against a struck-through $299); bundles are $76/$73/$69 per month on 3/6/12-month plans. Embody's Terms, updated July 1, 2026, promise 'no price increases on any of the plans.' Retired offers: the $199 Flat Program, and the Start Program at $99 for month one, then $299/month.
Checkout tile 'Flat rate at $119/month (strikethrough $349)'; homepage 'starting at $129/month'; bundles $126/$123/$119 per month.
New oral semaglutide $229/mo.
Oral tirzepatide $329/mo; gum bundles to $299/mo at 12-month.
NuuVim
What each price covers
Both prices cover the medication itself and shipping.
Embody's price also covers the clinician visit, which NuuVim does not claim.
Embody is silent on lab work and coaching.
NuuVim is silent on the clinician visit, lab work and coaching.
Embody
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
NuuVim
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Embody scores 9.3 and NuuVim 7.7 out of 10.
Embody is stronger on trust & safety (9.0 vs 3.5), accessibility (10.0 vs 5.0) and support (7.0 vs 4.5).
Value, effectiveness and user experience are within half a point.
Embody
9.3/10
NuuVim
7.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Embody nor NuuVim has an FDA warning letter on record with us.
Features & Coverage
| Feature | Embody | NuuVim |
|---|---|---|
| Starting Price | $79/mo | $79/mo |
| Features | 6 features | ✓7 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Embody
Embody sells compounded semaglutide and tirzepatide by injection, plus a compounded oral tirzepatide gum that is unique in the category. Flat-rate pricing is aggressive, coverage runs to all 50 states, and clinician messaging is available 24/7 under a board-certified internal medicine CMO.
Read our full Embody review →About NuuVim
NuuVim advertises compounded semaglutide from $79/month and tirzepatide from $133/month for new users, flat across all doses with no extra fees. The Texas-based program sells both injectable and oral forms, an uncommon oral option here, plus limited brand-name Ozempic and Zepbound. It is LegitScript-certified and HIPAA-compliant, serves all 50 states plus DC, and names two pharmacy partners.
Read our full NuuVim review →Pros & Cons
Embody
What we like
- Semaglutide costs $79 a month, 57% below the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $129 a month, 48% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Embody
- Offers both oral and injectable options, so the format is your choice
Watch-outs
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
NuuVim
What we like
- Semaglutide costs $79 a month, 57% below the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $133 a month, 47% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication and shipping
- We found no FDA warning letters issued to NuuVim
- Offers both oral and injectable options, so the format is your choice
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Embody wins this one, 9.3 to 7.7, above all for knowing which pharmacy fills the vial: it names RedRock Pharmacy. NuuVim fits better if semaglutide at $79/month, 58% below the typical price is your priority.
Choose Embody if…
You want knowing which pharmacy fills the vial: it names RedRock Pharmacy and an opening price near $79 a month.
Choose NuuVim if…
You want semaglutide at $79/month, 58% below the typical price and an opening price near $79 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Oak
Semaglutide at $119/month, 37% below the typical price
From $119/mo
Get started →Embody vs NuuVim: FAQ
Close alternatives to Embody and NuuVim
- Embody vs Good Girl Rx
- Embody vs Telos Rx
- Embody vs Try Ageless
- NuuVim vs Good Girl Rx
- NuuVim vs Ark Health
- NuuVim vs NuvaHealth
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.